Daniel Marbach

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Detecting Inter-Individual Contamination and Mismatches in Multiomics Next-Generation Sequencing Data.

Detecting Inter-Individual Contamination and Mismatches in Multiomics Next-Generation Sequencing Data.

Journal: Journal of visualized experiments : JoVE
Published: May 04, 2026

A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.

A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 09, 2026

A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.

A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 21, 2025

Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

Journal: Nature medicine
Published: June 03, 2025

Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.

Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.

Journal: Nature medicine
Published: March 21, 2025

Comparison of single-cell RNA-seq methods to enable transcriptome profiling of neutrophils in clinical samples.

Comparison of single-cell RNA-seq methods to enable transcriptome profiling of neutrophils in clinical samples.

Journal: Cell reports methods
Published: October 24, 2024

A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug development.

A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug development.

Journal: Communications biology
Published: October 02, 2024

Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor).

Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor).

Journal: BMC cancer
Published: July 22, 2024

Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma.

Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma.

Journal: EBioMedicine
Published: March 27, 2024

Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer.

Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 05, 2023

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

Journal: Blood
Published: November 27, 2023

Contextual AI models for single-cell protein biology.

Contextual AI models for single-cell protein biology.

Journal: Nature methods
Published: August 17, 2023
Showing 1-12 of 24

Last Updated: 09/26/2026